Table 1.
Characteristic | rtCGM (n = 30) | isCGM (n = 30) | P value |
---|---|---|---|
Male, % | 52 | 29 | 0.07 |
Age, years | 39.6 ± 12.2 | 37.8 ± 12.7 | 0.31 |
BMI, kg/m2 | 26.0 ± 4.2 | 24.9 ± 3.7 | 0.28 |
Duration of diabetes, years | 15.9 ± 11.4 | 14.4 ± 10.2 | 0.26 |
Microvascular complications, % | 33 | 27 | 0.78 |
DKA during lifetime, % | 27 | 30 | 0.99 |
Regular physical activity, % | 27 | 23 | 0.99 |
MDI therapy, % | 69 | 55 | 0.26 |
Total daily dose of insulin, units | 47.2 ± 4.8 | 47.4 ± 16.5 | 0.98 |
Frequency of SMBG/day, n | 4.4 ± 1.3 | 4.1 ± 0.9 | 0.55 |
HbA1c, mmol/mol | 61.1 ± 10.7 | 63.5 ± 13.9 | 0.46 |
HbA1c, % | 7.7 ± 1.0 | 8.0 ± 1.2 | 0.44 |
Gold score | 2.1 ± 0.9 | 2.1 ± 1.0 | 0.52 |
Data are mean ± SD unless otherwise indicated.
DKA, diabetic ketoacidosis; SMBG, self-monitoring of blood glucose.